Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bachy

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Haematologica|March 24, 2022
Mature T-cell neoplasms and stem cell transplant: the never-ending storyEmmanuel Bachy
Haematologica|February 15, 2024
Indirect treatment comparisons: how to MAIC it right?Emmanuel Bachy
The Lancet. Haematology|July 27, 2024
Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV-CHP?Edith Julia, Emmanuel Bachy
La Revue Du Praticien|March 13, 2010
[Prognostic factors in lymphomas]Emmanuel Bachy, Gilles Salles
Blood|January 27, 2025
Frontline treatment of follicular lymphoma: What will it take to change current practice?Emmanuel Bachy, Kim Linton
Best Practice & Research. Clinical Haematology|June 11, 2011
Marrow-ablative treatment and autologous stem cell transplantation in follicular NHLEmmanuel Bachy, Gilles Salles
Bulletin Du Cancer|September 10, 2022
[New European approvals: Tisagenlecleucel and Axicabtagene ciloleucel CAR-T cells - Follicular lymphoma after at least two and three prior lines of therapy]Stéphanie Cordeil, Emmanuel Bachy
Journal of Oncology Practice|March 13, 2019
Unravelling Subtleties of Angioimmunoblastic T-Cell LymphomaEmmanuel Bachy, Gilles Salles
The Lancet. Oncology|December 17, 2013
Anti-PD1 antibody: a new approach to treatment of lymphomasEmmanuel Bachy, Bertrand Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Reply to S. FujiEmmanuel Bachy, Gilles Salles
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Haematologica|March 24, 2022
Mature T-cell neoplasms and stem cell transplant: the never-ending storyEmmanuel Bachy
Haematologica|February 15, 2024
Indirect treatment comparisons: how to MAIC it right?Emmanuel Bachy
The Lancet. Haematology|July 27, 2024
Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV-CHP?Edith Julia, Emmanuel Bachy
La Revue Du Praticien|March 13, 2010
[Prognostic factors in lymphomas]Emmanuel Bachy, Gilles Salles
Blood|January 27, 2025
Frontline treatment of follicular lymphoma: What will it take to change current practice?Emmanuel Bachy, Kim Linton
Best Practice & Research. Clinical Haematology|June 11, 2011
Marrow-ablative treatment and autologous stem cell transplantation in follicular NHLEmmanuel Bachy, Gilles Salles
Bulletin Du Cancer|September 10, 2022
[New European approvals: Tisagenlecleucel and Axicabtagene ciloleucel CAR-T cells - Follicular lymphoma after at least two and three prior lines of therapy]Stéphanie Cordeil, Emmanuel Bachy
Journal of Oncology Practice|March 13, 2019
Unravelling Subtleties of Angioimmunoblastic T-Cell LymphomaEmmanuel Bachy, Gilles Salles
The Lancet. Oncology|December 17, 2013
Anti-PD1 antibody: a new approach to treatment of lymphomasEmmanuel Bachy, Bertrand Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Reply to S. FujiEmmanuel Bachy, Gilles Salles
Pageof 18